Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:664-668
Published online before print July 30, 2007, doi: 10.1161/CIRCULATIONAHA.106.671016
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/6/664    most recent
CIRCULATIONAHA.106.671016v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodenburg, J.
Right arrow Articles by Hutten, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodenburg, J.
Right arrow Articles by Hutten, B. A.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Related Collections
Right arrow Epidemiology
Right arrow Lipid and lipoprotein metabolism
Right arrow Primary prevention
Right arrow Risk Factors

(Circulation. 2007;116:664-668.)
© 2007 American Heart Association, Inc.


Pediatric Cardiology

Statin Treatment in Children With Familial Hypercholesterolemia

The Younger, the Better

Jessica Rodenburg, MD, PhD; Maud N. Vissers, PhD; Albert Wiegman, MD, PhD; A. S. Paul van Trotsenburg, MD, PhD; Anouk van der Graaf, MD; Eric de Groot, MD, PhD; Frits A. Wijburg, MD, PhD; John J.P. Kastelein, MD, PhD; Barbara A. Hutten, PhD

From the Departments of Vascular Medicine (J.R., M.N.V., A.v.d.G., E.d.G., J.J.P.K.), Paediatrics (A.W., A.S.P.v.T., F.A.W.), and Clinical Epidemiology, Biostatistics and Bioinformatics (B.A.H.), Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Correspondence to Barbara A. Hutten, PhD, Academic Medical Centre, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Meibergdreef 9, Room J1B-209–1, 1105 AZ Amsterdam, The Netherlands. E-mail b.a.hutten{at}amc.uva.nl

Received December 7, 2006; accepted May 25, 2007.

Background— We previously demonstrated in a randomized placebo-controlled trial that 2-year pravastatin treatment induced a significant regression of carotid intima-media thickness (IMT) in 8- to 18-year-old children with familial hypercholesterolemia. Subsequently, we continued to follow up these children to explore the relation between the age of statin initiation and carotid IMT after follow-up on statin treatment. We also examined safety aspects of statin therapy during this long-term follow-up.

Methods and Results— All 214 children who initially participated in the previous placebo-controlled study were eligible for the follow-up study. After completion of the placebo-controlled study, all children continued treatment with pravastatin 20 or 40 mg, depending on their age. Blood samples were taken on a regular basis for lipids and safety parameters, and a carotid IMT measurement was performed after an average treatment period of 4.5 years. Follow-up data for 186 children were available for the statistical analyses. Multivariate analyses revealed that age at statin initiation was an independent predictor for carotid IMT after follow-up with adjustment for carotid IMT at initiation of statin treatment, sex, and duration of treatment. Early initiation of statin treatment was associated with a subsequently smaller IMT. Furthermore, no serious laboratory adverse events were reported during follow-up, and statin treatment had no untoward effects on sexual maturation.

Conclusions— These data indicate that early initiation of statin treatment delays the progression of carotid IMT in adolescents and young adults. The present study shows for the first time that early initiation of statin therapy in children with familial hypercholesterolemia might be beneficial in the prevention of atherosclerosis in adolescence.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
CirculationHome page
D. Steinberg, C. K. Glass, and J. L. Witztum
Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia
Circulation, August 5, 2008; 118(6): 672 - 677.
[Full Text] [PDF]


Home page
CirculationHome page
I. Tabas, K. J. Williams, and J. Boren
Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications
Circulation, October 16, 2007; 116(16): 1832 - 1844.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. A. Stein
Statins and Children: Whom Do We Treat and When?
Circulation, August 7, 2007; 116(6): 594 - 595.
[Full Text] [PDF]